LRP5 and cancer: For example, single loci that exhibit diametric genetic effects on risk, such as LRP5 in OP and OA, and PIN1 in cancer and AD, demonstrate dosage-sensitive effects on disease-relevant pathways, which typically represent good indicators of enzyme or ligand-receptor systems that are especially amenable to pharmacological intervention.